QTc prolongation risk among patients receiving oral targeted antineoplastic medications: A real-world community-based oncology analysis

IntroductionThirty oral targeted antineoplastic agents are associated with prolongation of the QT interval. However, limited data exists regarding QTc prolongation and associated risk factors in the ambulatory oncology setting.MethodsThis retrospective study was completed to describe QTc prolongatio...

Full description

Bibliographic Details
Main Authors: David J. Reeves, Molly Russell, Vijay U. Rao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1098333/full